Stat

Boehringer Ingelheim’s Survodutide Shows Strong Weight‑Loss Results in Late‑Stage Trial

The Unseen Scars: When Hope Fades and Oncologists Grieve

The Unseen Weight: Oncologists and the Profound Burden of Grief

Medicare’s $50 GLP‑1 Weight‑Loss Plan: What the Numbers Really Mean

Medicare’s $50 Weight‑Loss Drug Plan: What the Numbers Really Mean

A New Chapter for Squamous Cell Lung Cancer: Harmoni’s Breakthrough at ASCO 2026

Day 2 at ASCO 2026: Fresh Data from BioNTech‑Pfizer, Kelun, Merck and Insights from Dr. Pazdur

Day 2 Highlights from ASCO 2026: Breakthroughs from BioNTech, Pfizer, Kelun, Merck and Insights by Dr. Eric Pazdur

A Glimmer of Hope: Rewriting the Future of Pancreatic Cancer Treatment

The Unveiling of Trump's Most Favored Nation Drug Pricing Secrets

The Unveiling: Trump's Most Favored Nation Drug Pricing Secrets Are About To Surface

Utah’s Doctronic AI Experiment Shows Early Promise in Transforming Patient Care

Kyle Diamantas Shines as Acting FDA Commissioner, Winning Trust Across the Board

Beyond the Hype: A Biotech CEO's Grounded View on AI in Drug Development

The Unseen Hand: How Pharma Giants Shape Policy Through Academic Influence

The Quiet Influence: Pharma's Play in Shaping Policy

Beyond the Budget: Charting a New Course for the NIH in a Post-Pandemic World

TrumpRx’s Generic Drug Push Falters as Cassidy’s FDA Battle Deepens

The Invisible Threat: Alcohol's Profound Impact on Unborn Lives

A Great Divide: American Biotech Grapples with the Ascendant Chinese Pharma Sector

Battle Lines Drawn: UK Health Advocates Prepare for Legal Fight Over US Pharma Trade Deal

Hantavirus on the High Seas: How a Cruise Ship Outbreak Echoed COVID‑19 Panic and Spawned Wild Theories

A Cruise Ship Hantavirus Outbreak Sparks COVID‑Era Flashbacks and Wild Conspiracy Theories

The FDA's Uphill Battle: Reclaiming Trust and Scientific Rigor in a New Era

Navigating the Dragon's Den: China's Evolving Role in Global Biotech

Dr. Nicole Saphier Unpacks Her Vision for Public Health as Surgeon General Nominee

Unpacking Tomorrow's Cancer Fight: Key Insights from AACR 2026

A New Dawn for Pancreatic Cancer: Unpacking the Revolutionary Science from AACR 2026

A Renewed Sense of Hope: Roche's Ocrevus Continues to Impress in MS Care

The Ripple Effect: How a Purdue Pharma Ruling Could Unsettle Pharma Settlements

A Digital Pioneer Departs: Andrew Baum's Exit from Pfizer

The Psychedelic Crossroads: Hope, Science, and the Shadow of Politics

Lilly's Strategic Gambit: Unpacking the Kelonia Therapeutics Partnership

The Quest for Hair: Nektar's Rezpeg Promises a New Dawn for Alopecia Sufferers

A New Era of Hope: Revolutionizing Pancreatic Cancer Treatment

A Game Changer? Allogene's 'Off-the-Shelf' CAR T Therapy Shows Stunning Promise in B-Cell Lymphoma

The Human Touch in a Machine World: Navigating AI's Impact on Healthcare Jobs

The Unraveling of Kezar Life Sciences: How an FDA Delay Triggered a Biotech Startup's Collapse

The Unspoken Irony: RFK Jr.'s Medical Freedom Paradox